Live Breaking News & Updates on Vaccine technology transfer

Stay informed with the latest breaking news from Vaccine technology transfer on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vaccine technology transfer and stay connected to the pulse of your community

IIT Guwahati completes tech transfer of vaccine to combat swine fever | Guwahati News

IIT Guwahati transfers pioneering vaccine technology for swine fever to BioMed Pvt Ltd, utilizing a reverse genetic platform for a highly contagious d

India , Bihar , Haryana , Kerala , Guwahati , Assam , Biomed-pvt-ltd , Department-of-biosciences , Assam-agricultural-university-in-guwahati , Indian-institute-of-technology , Indian-institute

IIT Guwahati completes technology transfer to BioMed for first recombinant vaccine for Swine Fever Virus

Indian Institute of Technology Guwahati transferred a pioneering vaccine technology to BioMed Pvt. Ltd. for a recombinant vector vaccine combating classical swine fever in pigs and wild boars, with research findings published in prestigious journals.

Kerala , India , Bihar , Haryana , Guwahati , Assam , Department-of-biosciences , Indian-institute-of-technology-guwahati , Assam-agricultural-university-in-guwahati , Indian-institute , Technology-guwahati

The Proposed WTO IP Waiver: Just What Good Can It Do? -- An Analysis | McDonnell Boehnen Hulbert & Berghoff LLP

As posted Monday, BIO (the Biotechnology Innovation Organization) provided a link to the supposed compromise agreement reached recently to permit WTO member states to waive patent...

New-york , United-states , South-africa , India , Andover , Pfizer , New-york-times , Vaccine-production-club , Biontech-agree-to-vaccine-technology , Africa-biovac-institute , World-bank-policy-research-working-paper

Is This the WTO Waiver End Game? | McDonnell Boehnen Hulbert & Berghoff LLP


Pfizer and BioNTech Agree to Vaccine Technology Transfer with South Africa's Biovac Institute
As reported by Reuters* on Wednesday (
e"), Pfizer and BioNTech, manufacturers and developers of an mRNA-based vaccine against SARS-CoV-2, have agreed to help the South African drug maker Biovac Institute produce about 100 million doses per year of its vaccine, specifically to be targeted to African nations.
As described by the Reuters article, Biovac Institute is "a joint venture between the South African government and private sector partners"; it has an advantage as being the first company in Africa to use mRNA technology to make the vaccine.  The scope of the cooperative agreement is limited to "fill and finish" aspects of the vaccine, leaving Pfizer and BioNTech to produce the mRNA components of the vaccine in Europe (for a more detailed description of the vaccine making process,

South-africa , South-african , Richard-pullin , Mark-potter , Andrei-iancu , Morena-makhoana , Cyril-ramaphosa , Reto-hilty , Wendell-roelf , Phrma-urge-biden-administration-to-oppose-proposed , World-health-organization , Biontech-agree-to-vaccine-technology